Login / Signup

A network-based drug prioritization and combination analysis for the MEK5/ERK5 pathway in breast cancer.

Regan OdongoAsuman Demiroglu-ZergerogluTunahan Çakir
Published in: BioData Min. (2024)
Keyphrases